Toxin-induced metabolic acidosis

Acid-Base Disorders and Their Treatment

Volumn , Issue , 2005, Pages 383-415

  Oh, Man S ^a   Halperin, Mitchell L ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85128084578     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (150)

1. Levy G. Clinical pharmacokinetics of aspirin. Pediatrics 1978; 62:867-872.
2. Davison C. Salicylate metabolism in man. Ann NY Acad Sci 1971; 179:249-268.
3. Brubacher JR, Hoffman RS. 1996 Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 1997; 34:431-443.
4. Rowlinson SW, Crews BC, Goodwin DC, Schneider C, Gierse JK, Marnett LJ. Spatial requirements for 15-(R)-hydroxy-5Z,11Z, 13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COW-1 does not synthesize 15-(R)-hete. J Biol Chem 2000; 275:6586-6591.
5. Schneider C, Brash AR. Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin-treated cyclooxygenase-2. Implications for the alignment of substrate in the active site. J Biol Chem 2000; 275:4743-4746.
6. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation ofhuman prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994; 269:13207-13215.
7. Hill JB. Experimental salicylate poisoning: observation of the effects of altering blood pH on tissue and plasma salicylate concentrations. Pediatrics 1971; 47:658-665.
8. Miyahara JT, Karler R. Effect of salicylate on oxidative phosphorylation and respiration of mitochondria fragments. Biochem J 1965; 97:194-198.
9. Seltzer HS. Drug-induced hypoglycemia: a review based on 473 cases. Diabetes 1972; 21:955-966.
10. Thurston JH, Pollock PG, Warren SK, Jones EM. Reduced brain glucose with normal plasma glucose in salicylate poisoning. J Clin Invest 1970; 49: 2139-2145.
11. Sainsbury SI. Fatal salicylate toxicity from bismuth subsalicylate. West J Med 1991; 55:637-739.
12. Singer RB. The acid-base disturbances in salicylate intoxication. Medicine (Baltimore) 1954; 33:1-15.
13. Winters RW, White IS, Hughes MC, Ordway NK. Disturbances of acid-base equilibrium in salicylate intoxication. Pediatrics 1959; 23:260-272.
14. Gabow PA, Anderson R, Potts DL, Schrier RW. Acid-base disturbances in the salicylate intoxicated adult. Arch Intern Med 1978; 138:1481-1484.
15. Alexander JK, Spalter HF, West JR. Modification of the respiratory response to carbon dioxide by salicylate. J Clin Invest 1955; 34:533-537.
16. Halperin ML, Connors HP, Relman AS, Karnovsky ML. Factors that control the effect of pH on glycolysis in leukocytes. J Biol Chem 1969; 244:384-390.
17. Roch-Ramel F, Guisan B. Renal transport of urate in humans. News Physiol Sci 1999; 14:80-84.
18. Myeres EN, Bernstein JM, Forstiropolous G. Salicylate ototoxicity. N Engl J Med 1965; 273:587-590.
19. Heffiner JE, Sahn SA. Salicylate-induced pulmonary edema. Ann Intern Med 1981; 95:405-409.
20. Berk WA, Anderson JC. Salicylate-associated asytole: report oftwo cases. Am J Med 1989; 86:505-506.
21. Chapman BJ, Proudfoot AT. Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med 1989; 72: 699-707.
22. Proudfoot AT, Brown SS. Acidemia and salicylate poisoning in adults. BMJ 1969; 2:547-553.
23. King JA, Storrow AB, Finkelstein JA. Urine Trinder spot test: a rapid salicylate. Ann Emerg Med 1995; 26:330-333.
24. Pierce RP, Gazewood J, Blake RL Jr. Salicylate poisoning from enteric coated aspirin: delayed absorption may complicate management. Postgrad Med 1991; 89:61-68.
25. Johnson D, Eppler J, Giesbrecht E. Effect of multiple-dose activated charcola on the clearance of high-dose intravenous aspirin in a porcine. Ann Emerg Med 1995; 26:569-574.
26. Lawson AAH, Proudfoot AT, Brown SS. Forced diuresis in the treatment of acute salicylate poisoning in adults. Q J Med 1969; 38:31-38.
27. Prescott LF, Balali-Mood M, Critchley JAJH. Diuresis or urinary alkalinzation for salicylate poisoning? Br Med J 1982; 285:1383-1386.
28. Jacobsen D, Wilk-Larsen E, Bredesen JE. Hemodialysis of hemoperfusion in severe salicylate poisoning? Hum Toxical 1988; 7:161-163.
29. Parry MF, Wallach R. Ethylene glycol poisoning. Am J Med 1974; 57: 143-150.
30. Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical Toxicology Practice Guidelines on the treatment of ethylene glycol poisoning. J Toxicol Clin Toxicol 1999; 37:537-560.
31. Johnson B, Meggs WJ, Bentzel CJ. Emergency department hemodialysis in a case of severe ethylene glycol poisoning. Ann Emerg Med 1999; 33:108-110.
32. Vasavada N, Williams C, Hellman RN. Ethylene glycol intoxication: case report and pharmacokinetic perspectives. Pharmacotherapy 2003; 23(12): 1652-1658.
33. Herold DA, Keil K, Bruns DE. Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem Pharmacol 1989; 38:73-76.
34. Clay KL, Murphy RC. On the metabolic acidosis of ethylene glycol intoxication. Toxicol Appl Pharmacol 1977; 39:39-49.
35. Poore RE, Hurst CH, Assimos DG, Holmes RP. Pathways of hepatic oxalate synthesis and their regulation. Am J Physiol 1997; 272:289-294.
36. Jacobsen D, Hewlett TP, Webb R, Brown ST, Ordinaro AT, McMartin KE. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med 1988; 84:145-152.
37. Moreau CL, Kerns W II, Tomaszewski CA, McMartin KE, Rose SR, Ford MD, Brent J, Group MS. Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. J Toxicol Clin Toxicol 1998; 36:659-666.
38. Gabow PA, Clay K, Sullivan JB, Lepoff R. Organic acids in ethylene glycol intoxication. Ann Intern Med 1986; 105:16-19.
39. Jacobsen D, Bredesen JE, Eide I, Ostborg J. Anion and osmolal gaps in the diagnosis of methanol and ethylene glycol poisoning. Acta Med Scand 1982; 212:17-23.
40. Godolphin W, Meagher EP, Sanders HD, Frohlich J. Unusual calcium oxalate crystals in ethylene glycol poisoning. Clin Toxicol 1980; 16:479-486.
41. Jacobsen D, Akesson J, Shefter E. Urinary calcium oxalate monohydrate crystals in ethylene glycol poisoning. Scand J Clin Lab Invest 1982; 42:231-234.
42. Huhn KM, Rosenberg FM. Critical clue to ethylene glycol poisoning. CMAJ 1995; 15:193-195.
43. Paulsen D, Kronborg J, Borg EB, Hagen T. Cigar-like oxalate crystals in ethylene glycol poisoning. Tidsskr Nor Laegeforen 1994; 114:435-436.
44. Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA. Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis 2001; 38(2):339-348.
45. Spillane L, Roberts JR, Meyer AE. Multiple cranial nerve deficits after ethylene glycol poisoning. Ann Emerg Med 1991; 20:208-210.
46. Eder AF, McGrath CM, Dowdy YG. Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis. Clin Chem 1998; 44: 168-177.
47. Jones AW, Nilsson L, Gladh SA, Karlsson K, Beck-Friis J. 2,3-Butanediol in plasma from an alcoholic mistakenly identified as ethylene glycol by gaschromatographic analysis. Clin Chem 1991; 37:1453-1455.
48. Darchy B, Abruzzese L, Pitiot O, Figueredo B, Domart Y. Delayed admission for ethylene glycol poisoning: lack of elevated serum osmol gap. Intensive Care Med 1999; 25:859-861.
49. Ammar KA, Heckerling PS. Ethylene glycol poisoning with a normal anion gap caused by concurrent ethanol ingestion: Importance of the osmolal gap. Am J Kidney Dis 1996; 27:130-133.
50. Scalley RD, Ferguson DR, Piccaro JC, Smart ML, Archie TE. Treatment of ethylene glycol poisoning. Am Fam Physician 2002; 66(5):807-812.
51. Peterson CD, Collins AJ, Himes JM, Bullock ML, Keane WF. Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med 1981; 304:21-23.
52. Davis LE, Hudson A, Benson BE, Jones Easom LA, Coleman JK. Methanol poisoning exposures in the United States: 1993-1998. J Toxicol Clin Toxicol 2002; 40(4):499-505.
53. Jacobsen D, Ovrebo S, Sejersted OM. Toxicokinetics of formate during hemodialysis. Acta Med Scand 1983; 214:409-412.
54. Eells JT, McMartin KE, Black K. Formaldehyde poisoning: rapid metabolism in formic acid. JAMA 1981; 246:1237-1238.
55. Matsumoto K, Moriya F, Nanikawa R. The movement of blood formaldehyde in methanol intoxication. II. The movement of blood formaldehyde and its metabolism in the rabbit. Nippon Hoigaku Zasshi 1990; 44:205-211.
56. Bennett IL, Cary FH, Mitchell GE, Cooper MN. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of323 cases. Medicine (Baltimore) 1953; 32:431-463.
57. Jacobsen D, Ovrebo S, Arnesen E, Paus PN. Pulmonary excretion ofmethanol in man. Scand J Clin Lab Invest 1983; 43:377-379.
58. Himes RH, Rabinowitz JC. Formyltetrahydrofolate synthetase. II. Characteristics of the enzyme and the enzyme reaction. J Biol Chem 1962; 237: 2903-2914.
59. Himes RH, Rabinowitz JC. Formyltetrahydrofolate synthetase. III. Characteristics of the enzyme and the enzyme reaction. J Biol Chem 1962; 237:2915-2925.
60. Johnlin FC, Fortman CS, Nghiem DD, Tephly TR. Studies on the role of folic acid and folate-dependent enzymes in human methanol poisoning. Mol Pharmacol 1987; 31:557-561.
61. McMartin KE, Martin-Amat G, Makar AB, Tephley TR. Methanol poisoning. V. Role of formate metabolism in the monkey. J Pharmacol Exp Therap 1977; 201:564-572.
62. Sejersted O, jacobsen D, Ovrebo S, Jansen H. Formate concentration in plasma from patients poisoned with methanol. Acta Med Scand 1983; 213:105-110.
63. Shahangian S, Ash KO. Formic and lactic acidosis in a fatal case of methanol intoxication. Clin Chem 1986; 32:395-396.
64. Smith SR, Snith SJM, Buckley BM. Combined formate and lactate acidosis in methanol poisoning. Lancet 1981; 2:1295-1296.
65. Leisivuori J, Savolainen H. Methanol and formate acid toxicity. Biochemical mechanisms. Pharmacol Toxicol 1991; 69:157-163.
66. Eells JT, Henry MM, Lewandowski MF, Seme MP, Murray TG. Development and characterization of a rodent model of methanol induced retinal and optic nerve toxicity. Neurotoxicology 2000; 21:321-330.
67. Liu JJ, Daya MR, Carrasquillo O, Kales SN. Prognostic factors in patients with methanol poisoning. J Toxicol Clin Toxicol 1998; 36:175-181.
68. Kuteifan K, Oesterle H, Tajahmady T, Gutbub AM, Laplatte G. Necrosis and haemorrhage of the putamen in methanol poisoning shown on MRI. Neurocardiology 1998; 40:158-160.
69. Chen JC, Schneiderman JF, Wortzman G. Methanol poisoning: bilateral putaminal and cerebellar cortical lesions on CT and MR. J Comput Assist Tomogr 1991; 15:522-524.
70. Haviv YS, Rubinger D, Zamir E, Safadi R. Pseudo-normal osmolal and anion gaps following simultaneous ethanol and methanol ingestion. Am J Nephrol 1998; 18:436-438.
71. Mycyk MB, Leikin JB. Antidote review: fomepizole for methanol poisoning. Am J Ther 2003; 10:68-70.
72. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 2002; 40(4):415-446.
73. Osterloh JD, Pond SM, Grady S, Becker CE. Serum formate concentration in methanol intoxication as a criterion for hemodialysis. Ann Intern Med 1986; 104:200-203.
74. McCoy HG, Gipole RJ, Ehlers SM. Severe methanol poisoning. Application of a pharmacokinetic model for ethanol therapy and hemodialysis. Am J Med 1979; 67:804-807.
75. Ellenhorn MJ, Schonwald S, Ordog G. Inhalant Abuse. Ellenhorn's Medi Toxicol 1997; 2:1493-1495.
76. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician 2003; 68(5):869-874.
77. Oettingen WF, Donahue DD. The toxicity and potential danger of toluene. JAMA 1942; 118:579-585.
78. Blake RC II, Coon MJ. On the mechanism of action of cytochrome P-450. Evaluation of homolytic and heterolytic mechanisms of oxygen-oxygen bond cleavage during substrate hydroxylation by peroxides. J Biol Chem 1981; 256:12127-12133.
79. Blake RC, Coon MJ. On the mechanism of action of cytochrome P-450. Role of peroxy spectral intermediates in substrate hydroxylation. J Biol Chem 1981; 256:5755-5773.
80. Carlisle EJF, Donnelly SM, Vasuvattakul S, Kamel KS, Tobe S, Halperin ML. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol 1991; 1:1019-1027.
81. Smith HW, Finfelstein N, Aliminosa L, Crawford B, Graber M. The renal clearances of substituted hippuric acid derivitives and other aromatic acids in dogs and man. J Clin Invest 1945; 24:388-404.
82. Jone CM, Wu AH. An unusual case of toluene-induced metabolic acidosis. Clin Chem 1988; 34:2596-2599.
83. Streicher H, Gabow P, Moss A, Kono D, Kaehny W. Syndromes of toluene sniffing in adults. Ann Intern Med 1981; 94:758-762.
84. Fichman CM, Oster JR. Toxic effects of toluene. A new cause of high anion gap metabolic acidosis. JAMA 1979; 241:11713-11715.
85. Batlle DC, Sabatini S, Kurtzman N. On the mechanism of toluene-induced renal tubular acidosis. Nephron 1988; 49:210-218.
86. Kamijima M, Nakazawa Y, Yamakawa M, Shibata E, Hisanaga N, Ono Y, Toida M, Takeuchi Y. Metabolic acidosis and renal tubular injury due to pure toluene inhalation. Arch Environ Health 1994; 49:410-413.
87. Gerkin RD Jr, LoVecchio F. Rapid reveral of life-threatening toluene-induced hypokalemia with hemodialysis. J Emerg Med 1998; 16:723-725.
88. Carlisle E, Donnelly S, Ethier J, Quaggin S, Kaiser U, Kamel K, Halperin M. Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int 1991; 39:1206-1212.
89. Shibata K, Yoshita Y, Matsumoto H. Extensive chemical burns from toluene. Am J Emerg Med 1994; 12:353-355.
90. Litovitz TL, Klein-Schwartz W, Caravati EM, Youniss J, Crouch B, Lee S. 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1999; 17:435-487.
91. Hass U, Lung SP, Hougaard KS. Developmental neurotoxicity after toluene inhalation exposure in rats. Neurotoxicol Teratol 1999; 21:349-357.
92. Einav S, Amitai Y, Reichman J, Geber D. Bradycardia in toluene poisoning. Clin Toxicol 1997; 35:295-298.
93. Steelman R, Goodman A, Biswas S, Zimmerman A. Metabolic acidosis and coma in a child with acetaminophen toxicity. Clin Pediatr (Phila) 2004; 43(2):201-203.
94. Ramsay RR, Rashed MS, Nelson SD. In vitro effects of acetaminophen metabolites and analogs on the respiration of mouse liver mitochondria. Arch Biochem Biophys 1989; 272:449-457.
95. Erstline RL, Ray SD, Ji S. Reversible and irreversible inhibition of hepatic mitochondrial respiration by acetaminophen and its toxic metabolites, N-acetyl-p-benzoquinoeneimine (NAPQI). Arch Biochem Biophys 1989; 38: 2387-2390.
96. Burcham PC, Harman AW. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J Biol Chem 1991; 266:5049-5054.
97. Landin JS, Cohen SD, Khairalla EA. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as a aldehyde dehydrogenase. Toxicol Appl Pharmacol 1996; 141:299-307.
98. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23(3):217-226.
99. Lee SP. Severe metabolic acidosis early in paracetamol poisoning. Brit Med J 1982; 285:851-852.
100. Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med 1999; 33:452-456.
101. Koulouris Z, Tierney MG, Jones G. Metabolic acidosis and coma following a severe acetaminophen overdose. Ann Pharmacotherap 1999; 33:1191-1193.
102. Gray TA, Buckley BM, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol poisoning. Quart J Med 1987; 65:811-821.
103. Pitt JJ, Brown GK, Clift V, Christodoulou J. Atypical pyroglutamic aciduria: possible role of paracetamol. J Inher Metab Dis 1990; 13:755-756.
104. Pitt JJ. Association between paracetamol and pyroglutamic aciduria. Clin Chem 1990; 36:173-174.
105. Bonham JR, Rattenbury JM, Meeks A, Pollitt RJ. Pyroglutamic aciduria from vigabatrin. Lancet 1989; 1:1452-1453.
106. Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med 2000; 28:1803-1807.
107. Freiman J, Helfert K, Hamrell M, Stein D. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7:379-385.
108. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med 1997; 25:1425-1430.
109. Olano JP, Borucki MJ, Wen JW, Haque AK. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 1995; 21:973-976.
110. Chattha G, Arieff AL, Cummings C, Tierney LM. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118: 37-39.
111. Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV cohort study. Clin Infect Dis 2001; 33:1931-1937.
112. Gopinath R, Hutcheson M, Cheema-Dhadli S, Halperin ML. Chronic lactic acidosis in a patient with acquired immunodeficienct syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol 1992; 3:1212-1219.
113. Schramm C, Wanitschke R, Galle PR. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis. Eur J Anaesthesiol 1999; 16: 733-735.
114. Jamieson CP, Obeig OA, Powell-Tuck J. The thiamin, riboflavin and pyridoxine status of patients on emergency admission to hospital. Clin Nutri 1999; 18:87-91.
115. Nolan CM, Elarth AM, Barr HW. Intentional isoniazid overdosage in young Southeast Asian refugee women. Chest 1988; 93:803-806.
116. Martinjak-Dvorsek I, Gorjup V, Horvat M, Noc M. Acute isoniazid neuro-toxicity during preventive therapy. Crit Care Med 2000; 28:567-568.
117. Sullivan EA, Geoffroy P, Weisman R, Hoffman R, Frieden TR. Isoniazid poisonings in New York city. J Emerg Med 1998; 16:57-59.
118. Shah BR, Santucci K, Sinert R, Steiner P. Acute isoniazid neurotoxicity in an urban hospital. Pediatrics 1995; 95:700-704.
119. Alvarez FG, Guntupalli KK. Isoniazid overdose: four case reports and review of the literature. Intensive Care Med 1995; 21:641-644.
120. Mayes PA. Structure and function of the water-soluble vitamins. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's Biochemistry. New York: McGraw-Hill, 1999:627-641.
121. Chin L, Sievers ML, Herrier RN, Picchioni AL. Convulsions as the etiology of lactic acidosis in acute isoniazid toxicity in dogs. Toxicol Appl Pharmacol 1979; 49:377-384.
122. Siskind MS, Thienemann D, Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron 1993; 64:303-306.
123. Pinto J, Huang YP, Rivlin RS. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. J Clin Invest 1981; 67:1500-1506.
124. Luzzati R, Del Bravo P, Di Perri G, Luzzani A, Concia E. Riboflavine and severe lactic acidosis. Lancet 1999; 353:901-902.
125. Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogue-inducing lactic acidosis. Lancet 1998; 352:291-292.
126. Lopez-Herce J. Benzyl alcohol poisoning following diazepam intravenous infusion. Ann Pharmacother 1995; 29:632.
127. LeBel M, Ferron L, Masson M, Pichette J, Carrier C. Benzyl alcohol metabolism and elimination in neonates. Dev Pharmacol Ther 1988; 11:347-356.
128. Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307:1384-1388.
129. Menon PA, Thach BT, Smith CH, Landt M, Roberts JL, Hillman RE, Hillman LS. Benzyl alcohol toxicity in a neonatal intensive care unit: Incidence, symptomatology, and mortality. Am J Perinatol 1984; 1:288-292.
130. Kehlner MJ, Bailey DN. Propylene glycol as a cause of lactic acidosis. J Anal Toxicol 1985; 9:40-42.
131. Woycik DL. Correction and comment possible toxicity from propylene glycol in injectible drug preparations. Ann Pharmacother 1997; 31:1413.
132. Seay RE. Comment possible toxicity from propylene glycol in lorazepam infusion. Ann Pharmacother 1997; 31:647-648.
133. McConnel JR. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1996; 38: 232-233.
134. Brooks DE, Wallace KL. Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2002; 40(4):513-516.
135. Christopher MM, Eckfeldt JH, Eaton JW. Propylene glycol ingestion causes d lactic acidosis. Lab Invest 1990; 62:114-118.
136. Rich J, Scheife RT, Katz N, Caplan LR. Isopropyl alcohol intoxication. Arch Neurol 1990; 47:322-324.
137. Rosansky SJ. Isopropyl alcohol poisoning treated with hemodialysis: kinetics of isopropyl alcohol and acetone removal. J Toxicol Clin Toxicol 1982; 19:265-271.
138. King LH Jr, Bradley KP, Shires DL Jr. Hemodialysis for isopropyl alcohol poisoning. JAMA 1970; 211:1855.
139. Wax PM. Elixirs, diluents, and the passage of the 1938. Federal Food, Drug and Cosmetic Act. Ann Intern Med 1995; 122:456-461.
140. O'Brien KL, Selanikio JD, Hecdivert C, et al. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning: acute renal failure investigation team. JAMA 1998; 279:1175-1180.
141. Hanif M, Mobarak MR, Ronan A, Rahman D, Donova JJ Jr, Bennish ML. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ 1995; 311:88-91.
142. Bowie MD, McKenzie D. Diethylene glycol poisoning in children. S A Med J 1972; 46:931-934.
143. Okuonghae HO, Ighogboja IS, Lawson JO, Nwana EJ. Diethylene glycol poisoning in Nigerian children. Ann Torp Paediatr 1992; 12:235-238.
144. Cantarell MC, Fort J, Camps J, Sans M, Piera L. An acute intoxication due to topical application of diethylene glycol. Ann Intern Med 1987; 106:478-479.
145. Wiener HL, Richardson KE. Metabolism of diethylene glycol in male rats. Biochem Pharmacol 1989; 38:539-541.
146. Borron SW, Baud FJ, Garnier R. Intravenous 4-methylpyrazole as an antidote for diethylene glycol and triethylene glycol poisoning: a case report. Vet Hum Toxicol 1997; 39:26-28.
147. Vassiliadis J, Graudins A, Dowsett RP. Triethylene glycol poisoning treated with intravenous ethanol infusion. J Toxicol Clin Toxicol 1999; 37:733-736.
148. Thompson WL, Johnson AD, Maddrey WL. Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med 1975; 82:175-180.
149. Gutman RA. Paraldehyde acidosis. Am J Med 1967; 42:435-440.
150. Hadden JW. Pseudoketosis and hyperacetaldehydemia in paraldehyde acidosis. Am J Med 1969; 47:642-647.